{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:03:32Z","timestamp":1790633012517,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015638","name":"Japanese Breast Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015638","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.breast.2025.104460","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T23:55:27Z","timestamp":1742946927000},"page":"104460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-2763","authenticated-orcid":false,"given":"Tomoe","family":"Taji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Kumamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7982-5213","authenticated-orcid":false,"given":"Yuki","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruto","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehira","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.breast.2025.104460_bib1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.breast.2025.104460_bib2","first-page":"970","article-title":"Understanding breast cancer complexity to improve patient outcomes: the St Gallen International Consensus Conference for the primary therapy of individuals with early breast cancer 2023","volume":"vol. 34","author":"Curigliano","year":"2023"},{"issue":"1","key":"10.1016\/j.breast.2025.104460_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","author":"Asselain","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104460_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-020-01907-7","article-title":"Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases","volume":"18","author":"Xia","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104460_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1245\/s10434-011-1877-y","article-title":"Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response","volume":"19","author":"Fisher","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104460_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jss.2010.04.015","article-title":"Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer","volume":"163","author":"Kennedy","year":"2010","journal-title":"J Surg Res"},{"issue":"9","key":"10.1016\/j.breast.2025.104460_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0222358","article-title":"Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: a report from the National Cancer Database","volume":"14","author":"Bagegni","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.breast.2025.104460_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-018-4727-9","article-title":"Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations","volume":"170","author":"Clifton","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2025.104460_bib9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.21873\/invivo.11594","article-title":"Efficacy of neoadjuvant versus adjuvant chemotherapy in hispanic\/latino (H\/L) women with local or locally advanced triple-negative breast cancer (TNBC)","volume":"33","author":"Philipovskiy","year":"2019","journal-title":"In Vivo (Brooklyn)"},{"issue":"4","key":"10.1016\/j.breast.2025.104460_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12282-020-01081-4","article-title":"Annual report of the Japanese Breast Cancer Society registry for 2016","volume":"27","author":"Kubo","year":"2020","journal-title":"Breast Cancer"},{"key":"10.1016\/j.breast.2025.104460_bib11","series-title":"General Rules for clinical and pathological recording of breast cancer","year":"2012"},{"key":"10.1016\/j.breast.2025.104460_bib12","series-title":"WHO classification of Tumours of the breast","author":"Lakhani","year":"2012"},{"issue":"3","key":"10.1016\/j.breast.2025.104460_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12282-016-0670-y","article-title":"The Japanese Breast Cancer Society clinical practice guideline for systemic treatment of breast cancer, 2015 edition","volume":"23","author":"Aihara","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.breast.2025.104460_bib14","unstructured":"Curigliano G, Burstein HJ, Winer EP, et al.De-escalating and escalating treatments for early-stage breast cancer: the st. Gallen International Expert Consensus Conference on the primary therapy of early breast cancer."},{"issue":"7","key":"10.1016\/j.breast.2025.104460_bib15","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1245\/s10434-024-15295-9","article-title":"ASO author reflections: increasing time of diagnosis to breast cancer surgery","volume":"31","author":"Kaufman","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104460_bib16","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.breast.2025.104460_bib17","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1245\/s10434-019-08050-y","article-title":"Time to surgery and the impact of delay in the non-neoadjuvant setting on triple-negative breast cancers and other phenotypes","volume":"27","author":"Mateo","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2025.104460_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.breast.2025.104460_bib19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.breast.2025.104460_bib20","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/sj.bjc.6604759","article-title":"Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer","volume":"99","author":"Sherrill","year":"2008","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.breast.2025.104460_bib21","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S1470-2045(22)00632-5","article-title":"Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial","volume":"23","author":"Mastro","year":"2022","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.breast.2025.104460_bib22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(17)30404-7","volume":"18","author":"Cameron","year":"2017","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.breast.2025.104460_bib23","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:52:46Z","timestamp":1763607166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625004771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":23,"alternative-id":["S0960977625004771"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104460","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104460"}}